BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17261345)

  • 1. Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
    Busquets S; Fuster G; Ametller E; Olivan M; Figueras M; Costelli P; Carbó N; Argilés JM; López-Soriano FJ
    Clin Nutr; 2007 Apr; 26(2):239-44. PubMed ID: 17261345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
    Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
    Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats.
    Figueras M; Busquets S; Carbó N; Barreiro E; Almendro V; Argilés JM; López-Soriano FJ
    FEBS Lett; 2004 Jul; 569(1-3):201-6. PubMed ID: 15225634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats.
    Carbó N; López-Soriano J; Costelli P; Busquets S; Alvarez B; Baccino FM; Quinn LS; López-Soriano FJ; Argilés JM
    Br J Cancer; 2000 Aug; 83(4):526-31. PubMed ID: 10945502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia?
    van Royen M; Carbó N; Busquets S; Alvarez B; Quinn LS; López-Soriano FJ; Argilés JM
    Biochem Biophys Res Commun; 2000 Apr; 270(2):533-7. PubMed ID: 10753659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
    Olivan M; Busquets S; Figueras M; Fontes de Oliveira C; Toledo M; Sette A; Ventura da Silva P; Barberis P; Argilés JM; López-Soriano FJ
    Clin Nutr; 2011 Feb; 30(1):33-7. PubMed ID: 20655130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the PPARgamma agonist GW1929 on muscle wasting in tumour-bearing mice.
    Moore-Carrasco R; Figueras M; Ametller E; López-Soriano FJ; Argilés JM; Busquets S
    Oncol Rep; 2008 Jan; 19(1):253-6. PubMed ID: 18097603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
    Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
    Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
    Wyke SM; Russell ST; Tisdale MJ
    Br J Cancer; 2004 Nov; 91(9):1742-50. PubMed ID: 15477867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
    Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
    Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
    Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
    Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer.
    Busquets S; Serpe R; Toledo M; Betancourt A; Marmonti E; Orpí M; Pin F; Capdevila E; Madeddu C; López-Soriano FJ; Mantovani G; Macciò A; Argilés JM
    Clin Nutr; 2012 Dec; 31(6):889-95. PubMed ID: 22608917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
    Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
    Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis.
    Llovera M; Garcia-Martinez C; Agell N; Lopez-Soriano FJ; Argiles JM
    Int J Cancer; 1995 Mar; 61(1):138-41. PubMed ID: 7705927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
    McCarthy DO; Whitney P; Hitt A; Al-Majid S
    Res Nurs Health; 2004 Jun; 27(3):174-84. PubMed ID: 15141370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
    Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
    J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model.
    Busquets S; Carbó N; Almendro V; Quiles MT; López-Soriano FJ; Argilés JM
    Cancer Lett; 2001 Jun; 167(1):33-8. PubMed ID: 11323096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma.
    Carbó N; Costelli P; Busquets S; López-Soriano J; López-Soriano FJ; Baccino FM; Argilés JM
    Int J Mol Med; 2004 Oct; 14(4):719-23. PubMed ID: 15375607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.